US98973P1012 - ZIOP - A0JMYA (XNAS)
ZIOPHARM ONCOLOGY INC Aktie
Performance
Tag | Woche | Monat | 3 Monate | 6 Monate | 1 Jahr | 5 Jahre |
---|---|---|---|---|---|---|
- | - | - | - | 0,00 % | 0,00 % | -81,10 % |
Firmenprofil zu ZIOPHARM ONCOLOGY INC Aktie
ZIOPHARM Oncology, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing a portfolio of immuno-oncology therapies to treat patients with cancer. The company develops Sleeping Beauty platform, which is based on the non-viral genetic engineering of immune cells using a transposon/transposase system to engineer T-cells outside of the body for infusion; and Controlled IL-12 to stimulate expression of interleukin 12 or IL-12, a master regular of the immune system, in a controlled manner to focus the patient's immune system to attack cancer cells. Its product candidates include T cell receptor + T therapies to target solid tumors; chimeric antigen receptor + T cell therapies targeting CD19 for hematologic malignancies; and Ad-RTS-hIL-12 plus veledimex, a gene delivery system to regulate production of IL-12 to treat patients with recurrent glioblastoma multiforme in adults. The company has a license agreement with PGEN Therapeutics, Inc.; research and development agreement with The University of Texas MD Anderson Cancer Center; a patent license agreement with the National Cancer Institute; and a cooperative research and development agreement with the National Cancer Institute. ZIOPHARM Oncology, Inc. is headquartered in Boston, Massachusetts.
Investierte Fonds
Folgende Fonds haben in ZIOPHARM ONCOLOGY INC investiert:
Fonds | Vol. in Mio 11,89 | Anteil (%) 0,03 % |
Unternehmensdaten zur ZIOPHARM ONCOLOGY INC Aktie
Name ZIOPHARM ONCOLOGY INC
Firma ZIOPHARM Oncology, Inc.
Symbol ZIOP
Website https://ziopharm.com
Heimatbörse
NASDAQ
WKN A0JMYA
ISIN US98973P1012
Wertpapierart Aktie
Sektor Healthcare
Branche Biotechnology
CEO Dr. Laurence Cooper
Marktkapitalisierung 208 Mio
Land Vereinigte Staaten von Amerika
Währung USD
Mitarbeiter 0,1 T
Adresse One First Avenue Parris Building 34, Navy Yard Plaza, 02129 Boston
IPO Datum 2004-08-20
Aktien-Splits
Datum | Split |
---|---|
24.08.2005 | 1:40 |
Ticker Symbole
Name | Symbol |
---|---|
NASDAQ | ZIOP |
Weitere Aktien
Investoren die ZIOPHARM ONCOLOGY INC halten haben auch folgende Aktien im Depot:
Die Finanzplattform goSPATZ trackt und analysiert Investitionen und Portfolios.
Vom Wertpapier-Depot bis zum Crypto-Kauf.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
All rights reserved © LCP GmbH 2024